HomeCompareSALRY vs JNJ

SALRY vs JNJ: Dividend Comparison 2026

SALRY yields 1.77% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SALRY wins by $971.0K in total portfolio value
10 years
SALRY
SALRY
● Live price
1.77%
Share price
$14.65
Annual div
$0.26
5Y div CAGR
74.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$991.0K
Annual income
$696,226.68
Full SALRY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SALRY vs JNJ

📍 SALRY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSALRYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SALRY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SALRY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SALRY
Annual income on $10K today (after 15% tax)
$150.85/yr
After 10yr DRIP, annual income (after tax)
$591,792.68/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SALRY beats the other by $591,089.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SALRY + JNJ for your $10,000?

SALRY: 50%JNJ: 50%
100% JNJ50/50100% SALRY
Portfolio after 10yr
$505.5K
Annual income
$348,527.23/yr
Blended yield
68.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SALRY
No analyst data
Altman Z
2.2
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SALRY buys
0
JNJ buys
0
No recent congressional trades found for SALRY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSALRYJNJ
Forward yield1.77%3.36%
Annual dividend / share$0.26$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR74.5%5.8%
Portfolio after 10y$991.0K$20.0K
Annual income after 10y$696,226.68$827.78
Total dividends collected$942.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SALRY vs JNJ ($10,000, DRIP)

YearSALRY PortfolioSALRY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,010$309.69$10,676$355.77+$334.00SALRY
2$12,336$556.06$11,407$389.39+$929.00SALRY
3$14,216$1,016.12$12,198$426.53+$2.0KSALRY
4$17,121$1,909.62$13,056$467.62+$4.1KSALRY
5$22,070$3,750.62$13,987$513.12+$8.1KSALRY
6$31,500$7,884.79$14,998$563.56+$16.5KSALRY
7$52,058$18,352.96$16,098$619.52+$36.0KSALRY
8$105,166$49,464.80$17,295$681.69+$87.9KSALRY
9$275,496$162,967.57$18,599$750.82+$256.9KSALRY
10$991,007$696,226.68$20,022$827.78+$971.0KSALRY

SALRY vs JNJ: Complete Analysis 2026

SALRYStock

SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, the United States, Canada, Norway, rest of Europe, and internationally. It is involved in the broodfish, lumpfish, and smolt production activities; and marine-phase farming, harvesting, packaging, processing, and selling farmed salmon. The company sells its products to importers/exporters, processing companies, and retail chains through in-house sales force and/or through partners. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.

Full SALRY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SALRY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SALRY vs SCHDSALRY vs JEPISALRY vs OSALRY vs KOSALRY vs MAINSALRY vs ABBVSALRY vs MRKSALRY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.